《外圍股市》美股期貨全面反覆靠穩 納指期貨回升0.2%
亞太區股市個別發展,但除菲股續跌1.1%外,其餘升跌均不足0.8%,其中日經回吐0.7%,港股受重磅股騰訊(00700.HK)/美團(03690.HK)反覆偏軟、內房及體育股顯著回吐拖累反覆回吐0.1%報26,100。相反,滬指及深成全日高收3,609及14,596,分別回升近0.8%及續升0.7%;已四連吐的印度孟買、澳股及韓股反覆升不足0.5%。
美股期貨全面靠穩,其中道指期貨高低見35,588/35,451,現報35,563,反覆續升6點;納指一百期貨最低見15,295,現報15,373,回升0.2%;標普五百期貨最低見4,522,現報4,541,回升4點或0.1%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.